Advisory: Alerts on CEO and chairman appointment wrongly tagged to Orient Bio withdrawn
11/08/2025 14:20
Alerts from real-time aggregator for rideshare prices Obi appointing Ashwini Anburajan as its CEO and Payam Safa as chairman, was inadvertently tagged to Korea-based biotechnology company Orient Bio 002630.KS, an unrelated entity, and have been withdrawn. There will be no substitute. STORY_NUMBER: nTUA5NBFBG STORY_DATE: 11/08/2025 STORY_TIME: 01:00 PM GMT ((Bangalore.newsroom@thomsonreuters.com))
Recent news on Orient Bio
See all newsBrief: Orient Bio To Sell 9.4 Billion Won Of Own Shares
Advisory: Alerts on CEO and chairman appointment wrongly tagged to Orient Bio withdrawn
S.Korea's MERS-related shares surge on hopes of higher demand for products
Brief: Orient Bio lowers exercise price of 12th series bonds with warrants to 1,030 won/share
Brief: Orientbio lowers exercise price of 12th series bonds with warrants to 1,190 won/share